RS1 gene is a novel prognostic biomarker for lung adenocarcinoma.
Tao ZhangGuowei ChengPing ChenYue PengLei LiuRunze LiBin Qiu
Published in: Thoracic cancer (2022)
In conclusion, our study suggests that RS1 is a novel prognostic biomarker for LUAD. Differences in immune cell infiltration and signaling pathways may contribute to the poor prognosis of LUAD caused by low RS1 expression.